Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseasesNathan A. Berger, Csaba Szabó, Peter Radermacher et al.|British Journal of Pharmacology|2017Cited by 210
Decreased microglial Wnt/β-catenin signalling drives microglial pro-inflammatory activation in the developing brainJuliette Van Steenwinckel, Pierre Gressèns, Anne‐Laure Schang et al.|Brain|2019Cited by 140
Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brainRaffaella Moretti, Christiane Charriaut‐Marlangue, Pierre‐Louis Léger et al.|Journal of Neuroinflammation|2016Cited by 61
Sex differences in the effects of PARP inhibition on microglial phenotypes following neonatal strokeChristiane Charriaut‐Marlangue, Valérie C. Besson, Claire Leconte et al.|Brain Behavior and Immunity|2018Cited by 31
<scp>miR</scp>‐146b Protects the Perinatal Brain against Microglia‐Induced HypomyelinationCindy Bokobza, Juliette Van Steenwinckel, Pooja Joshi et al.|Annals of Neurology|2021Cited by 31